Hensin Tsao MD, PhD
Clinical Director, MGH Melanoma & Pigmented Lesion Center; Director, MGH Melanoma Genetics Program, Massachusetts General Hospital, Boston, MassachusettsHensin Tsao, MD, PhD is a board-certified dermatologist and Professor of Dermatology at Harvard Medical School. Presently, he is Director of the Melanoma and Pigmented Lesion Center, the Melanoma Genetics Program, and the Skin Cancer Genetics Laboratory in the Wellman Center for Photomedicine, all of which are at the Massachusetts General Hospital. Beyond patient care, he dedicates much of his time to melanoma research and the education of medical students, dermatology residents, and fellows.
Hensin Tsao, MD, PhD received his undergraduate degree from Brown University where he graduated magna cum laude and Phi Beta Kappa. Later, he graduated Alpha Omega Alpha from the Columbia University College of Physicians and Surgeons with a MD degree and received his PhD from Columbia University Graduate School of Arts of Sciences. Dr. Tsao completed one year of clinical training in internal medicine and three years of dermatology residency, including one-year Melanoma Fellowship in the Harvard-affliated hospitals. He concluded his training with a postdoctoral fellowship in the Division of Oncology at Massachusetts General Hospital.
Dr. Tsao supervises an active cancer genetics laboratory and is the author of more than 100 scholarly articles, reiews, abstracts, textbook chapters, and online media texts. He has also delivered more than 100 lectures on melanoma, genetics, and skin disease throughout the world.
Disclosures
Dr. Tsao has no relevant disclosures.Recent Contributions to PracticeUpdate:
- Melanoma Screening and Public Education for Minority Populations in the US
- The Purpose and Importance of Dermatology Boards
- Frontline BRAF Testing–Guided Treatment for Advanced Melanoma in the Era of Immunotherapies
- Dabrafenib Plus Trametinib in Metastatic Melanoma
- Use of a Noninvasive Two-Gene Molecular Assay for Cutaneous Melanoma and Impact on Biopsy